retatrutide weight loss phase 2 trial results New 3 obesity trials came out and the are impressive: - 1,152 patients with obesity & type diabetes 🚨 BREAKING: Retatrutide Shows “Bariatric-Level”

Chronic financial stress linked to housing insecurity, unstable employment and transportation barriers shapes health behaviors and physiology in ways that make weight management harder

Participants without diabetes averaged 22.4% weight loss at 48 weeks (8mg dose), while those with type 2 diabetes averaged 19.7%

Compounded tirzepatide dosage: how starting doses are usually discussed Follow your prescriber's instructions The schedule below mirrors the FDA-approved label schedule for brand-name tirzepatide (Zepbound/Mounjaro)

Peptides and Testosterone Stack: The Complete Guide Interested in BPC-157 or testosterone optimization

Reduction is gated on stored fat: the participants in that substudy all started with at least 10% liver fat, and the size of the drop tracked how much was there at baseline

Renal adaptation to dietary carnitine in humans